New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 7, 2014
05:55 EDTKINKindred Biosciences downgraded to Neutral from Buy at Roth Capital
Roth Capital downgraded Kindred Biosciences citing valuation following the company's Q4 results but raised its price target for shares to $25 from $20.
News For KIN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 19, 2014
07:09 EDTKINJefferies to hold a conference
2014 Global London Healthcare Conference is being held in London, England on November 19-20.
November 13, 2014
16:06 EDTKINKindred Biosciences reports Q3 EPS(31c), consensus (45c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use